Capital Advisors Inc. OK Reduces Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Capital Advisors Inc. OK lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 10.8% in the 4th quarter, HoldingsChannel reports. The fund owned 1,045 shares of the company’s stock after selling 127 shares during the period. Capital Advisors Inc. OK’s holdings in HCA Healthcare were worth $314,000 as of its most recent filing with the SEC.

Several other institutional investors have also added to or reduced their stakes in the business. Creative Planning boosted its holdings in HCA Healthcare by 37.6% in the 3rd quarter. Creative Planning now owns 47,589 shares of the company’s stock worth $19,342,000 after buying an additional 13,015 shares during the period. Swedbank AB grew its position in shares of HCA Healthcare by 1.2% in the third quarter. Swedbank AB now owns 286,219 shares of the company’s stock valued at $116,328,000 after purchasing an additional 3,436 shares in the last quarter. Sunpointe LLC boosted its stake in HCA Healthcare by 8.2% in the 3rd quarter. Sunpointe LLC now owns 1,026 shares of the company’s stock worth $417,000 after purchasing an additional 78 shares during the period. Sumitomo Life Insurance Co. lifted its holdings in shares of HCA Healthcare by 3.2% in the third quarter. Sumitomo Life Insurance Co. now owns 2,291 shares of the company’s stock worth $931,000 after buying an additional 72 shares in the last quarter. Finally, Terra Nova Asset Management LLC grew its stake in HCA Healthcare by 0.3% during the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after acquiring an additional 26 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

HCA opened at $312.55 on Thursday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The stock’s 50 day simple moving average is $313.49 and its 200 day simple moving average is $353.04. The firm has a market cap of $79.17 billion, a price-to-earnings ratio of 14.23, a PEG ratio of 1.11 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the company posted $5.90 earnings per share. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.92%. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is currently 12.02%.

Analysts Set New Price Targets

HCA has been the subject of a number of recent analyst reports. Oppenheimer boosted their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Barclays decreased their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. Morgan Stanley cut their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.